Arcturus Therapeutics is actively engaged in partnering discussions. Our strategic alliances fall into several categories:
- Partnering RNA medicines, including access to LUNAR and UNA Technologies
- Co-Development Opportunities
Please contact bd@arcturusrx.com regarding any business development opportunities.
News & Events
July 10, 2019
Arcturus Therapeutics to Participate in Two Panels at the ROTH RNA Revolution Conference
June 27, 2019
Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-810, for Treatment of Ornithine Transcarbamylase (OTC) Deficiency
June 19, 2019
Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases